BGC20-1531 hydrochloride|CAS 1186532-61-5|DC Chemicals

Cas No.:	1186532-61-5
Chemical Name:	BGC-20-1531
Synonyms:	BGC-20-1531;AP-1531;sodium 4-[4-(5-methoxypyridin-2-yl)phenoxymethyl]-5-methylfuran-2-carbonyl(2-methylbenzenesulfonyl)azanide;AKOS040759607;1186532-61-5;BGC20-1531;9QV7JG4XYZ;2-FURANCARBOXAMIDE, 4-((4-(5-METHOXY-2-PYRIDINYL)PHENOXY)METHYL)-5-METHYL-N-((2-METHYLPHENYL)SULFONYL)-, SODIUM SALT (1:1);AC-36663;EX-A4850;PGN 1531;SB18901;CHEMBL3260771;CID 25209437;BGC 20-1531;sodium;[4-[[4-(5-methoxypyridin-2-yl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanide;sodium (4-((4-(5-methoxypyridin-2-yl)phenoxy)methyl)-5-methylfuran-2-carbonyl)(o-tolylsulfonyl)amide;BDBM50012548;4-((4-(5-METHOXY-2-PYRIDYL)PHENOXY)METHYL)-5-METHYL-N-(O-TOLYLSULFONYL)FURAN-2-CARBOXAMIDE; SODIUM HYDRIDE;SCHEMBL2355810
SMILES:	S(C1C=CC=CC=1C)([N-]C(C1=CC(COC2C=CC(C3C=CC(=CN=3)OC)=CC=2)=C(C)O1)=O)(=O)=O.[Na+]
Formula:	C₂₆H₂₃N₂NaO₆S
M.Wt:	514.525396585464
Purity:	>98%
Sotrage:	0°C (short term), -20°C (long term), desiccated

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.